The company’s innovations have not gone unnoticed. AI Medical Service was featured in 
SONIRE’s approach, which utilizes cavitation to enhance treatment accuracy, has been recognized by the U.S. FDA as a breakthrough device. The company is currently conducting a world-first randomized trial to further validate the efficacy of their technology. As CEO Satoh Tohru notes, the goal is to offer a more effective and safer cancer treatment to patients worldwide.
These Japanese startups are not only advancing medical technology but also providing hope for millions of cancer patients globally. As the world braces for a surge in cancer cases, innovations from companies like AI Medical Service and SONIRE Therapeutics could be pivotal in changing the landscape of cancer treatment.
Increased Costs for Mortgage Lenders: Credit Reports in 2024
In a significant development for the mortgage lending industry, the Fair Isaac Corporation (FICO) has announced changes to its pricing structure for credit reports, set to take effect in 2024. This decision will have far-reaching implications for mortgage lenders, as FICO moves away from the tier-based pricing system introduced in 2023. The new pricing structure, which entails a single, higher price for all lenders, has raised concerns among industry players, particularly smaller lenders. Credit reports play a vital role in the mortgage lending process, serving as a key tool for lenders to assess the creditworthiness of borrowers. With this shift in pricing, lenders will need to adapt their budgets and pricing strategies to accommodate the increased costs. The potential impact on borrowers remains uncertain, as lenders may pass on the higher expenses through increased fees or interest rates.
